Inferior Vena Cava Filters

 

 Buy Article Permissions and Reprints

ABSTRACT

Venous thromboembolism (VTE) remains a common disease with significant clinical impact upon our patients. Diagnostic challenges occur because of the nonspecific nature of the presenting symptoms. The advent of multidetector computed tomography, methods to stratify patients into VTE risks (low, intermediate, high) along with serological assays (D-dimers), have helped direct patients through proper workup and into conclusive diagnosis. In most cases, standard medical therapy for VTE is anticoagulation therapy (OAT). In situations where standard OAT is either contraindicated or complications result from that therapy, insertion of inferior vena cava (IVC) filters is considered. Recent reports suggest that although IVC filters are able to prevent pulmonary emboli (PE) in the short and intermediate term, there appear to be long-term consequences including excess recurrent deep venous thombosis (DVT and IVC/filter occlusions). Recognition of the time sequence of IVC filter benefits and complications has encouraged development of optional IVC filters, which can be left in place indefinitely or removed usually before certain time constraints. This article will attempt to address the timing of IVC filter placements to protect patients from significant PE.

REFERENCES

• 1 White R H. The epidemiology of venous thromboembolism.  Circulation. 2003;  107 I4-I8
  PubMedGoogle Scholar
• 2 Barritt D W, Jordan S C. Anticoagulant drugs in treatment of pulmonary embolisms: a controlled clinical trail.  Lancet. 1960;  1 1309-1312
  PubMedGoogle Scholar
• 3 Levine M, Raskob G E, Landefeld C S, Kearnon C. Hemorrhage complications after anticoagulation treatment.  Chest. 1998;  114(suppl) 511S-523S
  CrossrefPubMedGoogle Scholar
• 4 Kinney T B. Update on inferior vena cava filters.  J Vasc Interv Radiol. 2003;  14 425-430
  CrossrefPubMedGoogle Scholar
• 5 Greenfield L J. Evolution of venous interruption for pulmonary thromboembolism.  Arch Surg. 1992;  127 622-626
  PubMedGoogle Scholar
• 6 Greenfield L J, McCrudy J R, Brown P P, Elkins R S. A new intracaval filter permitting continued flow and resolution of emboli.  Surgery. 1973;  73 599-606
  PubMedGoogle Scholar
• 7 Becker D M, Philbrick J T, Selby J B. Inferior vena cava filters.  Arch Intern Med. 1992;  152 1985-1994
  CrossrefPubMedGoogle Scholar
• 8 Streiff M B. Vena caval filters: a comprehensive review.  Blood. 2000;  95 3669-3677
  PubMedGoogle Scholar
• 9 Girard P, Stern J P, Parent F. Medical literature and vena cava filters: so far so weak.  Chest. 2002;  122 963-967
  CrossrefPubMedGoogle Scholar
• 10 Brender E. Use of emboli-blocking filters increases, but rigorous data are lacking.  JAMA. 2006;  295 989-990
  CrossrefPubMedGoogle Scholar
• 11 Decousus H, Leizorovicz A, Parent A et al.. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention Du Risque D'Embolie Pulmonaire Par Interruption Cave Study group.  N Engl J Med. 1998;  338 409-415
  CrossrefPubMedGoogle Scholar
• 12 The PREPIC study group . Eight year follow-up of patients with permanent vena cava filters in prevention of pulmonary embolism. The PREPIC (Prévention Du Risque D'Embolie Pulmonaire par Interruption Cave) Randomized Study.  Circulation. 2005;  112 416-422
  CrossrefPubMedGoogle Scholar
• 13 Girard P, Musset D, Parent F, Maitre S, Philippoteau C, Simonneau G. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism.  Chest. 1999;  116 903-908
  CrossrefPubMedGoogle Scholar
• 14 Hyers T M. Management of venous thromboembolism: past, present, and future.  Arch Intern Med. 2003;  163 759-768
  CrossrefPubMedGoogle Scholar
• 15 Barritt D W, Jordan S C. Anticoagulant drugs in treatment of pulmonary embolism: a controlled trial.  Lancet. 1960;  1 1309-1312
  PubMedGoogle Scholar
• 16 Cundiff D K, Manyemba J, Pezzullo J C. Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism.  Cochrane Database Syst Rev. 2006;  (1) CD003746
  PubMedGoogle Scholar
• 17 Douketis J D, Kearon C, Bates S et al.. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.  JAMA. 1998;  279 458-462
  CrossrefPubMedGoogle Scholar
• 18 Heit J A. Venous thromboembolism: disease burden, outcomes and risk factors.  J Thromb Haemost. 2005;  3 1611-1617
  CrossrefPubMedGoogle Scholar
• 19 Palareti G, Manotti C, D'Angelo A et al.. Thrombotic events during oral anticoagulation treatment: results of inception-cohort, prospective, collaborative ISCOAT study.  Thromb Haemost. 1997;  78 1438-1443
  PubMedGoogle Scholar
• 20 Kaufman J, Kinney T B, Streiff M B et al.. Guidelines for the use of retrievable and convertible vena cava filters: report for the SIR multidisciplinary consensus conference.  J Vasc Interv Radiol. 2006;  17 449-459
  CrossrefPubMedGoogle Scholar
• 21 Jones T K, Barnes R W, Greenfield L J. Greenfield vena caval filter: rationale and current indications.  Ann Thorac Surg. 1986;  42(suppl) S48-S55
  PubMedGoogle Scholar
• 22 Barker N W, Nygaard K K, Walters W, Priestly J T. A statistical study of postoperative venous thrombosis and pulmonary embolism: III. Time of occurrence during the post operative period.  Proc Staff Mayo Clin. 1941;  16 17-21
  PubMedGoogle Scholar
• 23 Norris C S, Greenfield L J, Herrmann J B. Free-floating iliofemoral thrombus.  Arch Surg. 1985;  120 806-808
  PubMedGoogle Scholar
• 24 Pacouret G, Alison D, Pottier J M, Bertrand P, Charbonnier B. Free-floating thrombus and embolic risk with angiographically confirmed proximal deep venous thrombus: a prospective study.  Arch Intern Med. 1997;  157 305-308
  PubMedGoogle Scholar
• 25 Dalen J E, Alpert J S. Natural history of pulmonary embolism.  Prog Cardiovasc Dis. 1975;  17 259-270
  CrossrefPubMedGoogle Scholar
• 26 Greenfield L J, Peyton M D, Brown P P, Elkins R C. Transvenous management of pulmonary embolic disease.  Ann Surg. 1974;  180 461-468
  PubMedGoogle Scholar
• 27 The urokinase pulmonary embolism trial: a national cooperative study.  Circulation. 1973;  47(suppl 2) II1-II108
  PubMedGoogle Scholar
• 28 Greenfield L J, Scher L A, Elkins R C. KMA-Greenfield filter placement for chronic pulmonary hypertension.  Ann Surg. 1979;  189 560-565
  PubMedGoogle Scholar
• 29 Peyton J W, Hylemon M B, Greenfield L J et al.. Comparison of Greenfield filter and vena cava ligation for experimental septic thromboembolism.  Surgery. 1983;  93 533-537
  PubMedGoogle Scholar
• 30 Greenfield L J, Proctor M C. Vena cava filter use in patients with sepsis: results in 175 patients.  Arch Surg. 2003;  138 1245-1248
  CrossrefPubMedGoogle Scholar
• 31 Shimizu M, Tatsumi K, Matsukawa R, Shima T, Miwa Y. Retrievable Günther Tulip filter complicated by sepsis and retroperitoneal hemorrhage: successful management by filter retrieval.  Intern Med. 2005;  44 593-597
  CrossrefPubMedGoogle Scholar
• 32 Antevil J L, Sise M J, Sack D I et al.. Retrievable vena cava filters for preventing pulmonary embolism in trauma patients: a cautionary tale.  J Trauma. 2006;  60 35-40
  CrossrefPubMedGoogle Scholar
• 33 Moore B S, Valji K, Roberts A C, Bookstein J J. Transcatheter manipulation of asymmetrically opened Greenfield filters.  J Vasc Interv Radiol. 1993;  4 687-690
  PubMedGoogle Scholar
• 34 Greenfield L J, Proctor M C. Experimental embolic capture by asymmetric Greenfield filters.  J Vasc Surg. 1992;  16 436-465
  CrossrefPubMedGoogle Scholar
• 35 Kinney T B, Rose S C, Weingarten K E et al.. IVC filter tilt and asymmetry: comparison of the over-the-wire stainless steel and titanium Greenfield IVC filters.  J Vasc Interv Radiol. 1997;  8 1029-1037
  CrossrefPubMedGoogle Scholar
• 36 David W, Gross W S, Colaiuta E, Gonda R, Osher D, Launti S. Pulmonary embolus after vena cava filter placement.  Am Surg. 1999;  65 341-346
  PubMedGoogle Scholar
• 37 Rogers F B, Cipolle M D, Velmahos G, Royzyki G, Luchette F A. Practice management guidelines for prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group.  J Trauma. 2002;  53 142-164
  CrossrefPubMedGoogle Scholar
• 38 Lorch H, Zwaan M, Siemens H J, Wagner T, Kagel C, Weiss H D. Temporary vena cava filters and ultrahigh streptokinase thrombolysis therapy: a clinical study.  Cardiovasc Intervent Radiol. 2000;  23 273-278
  CrossrefPubMedGoogle Scholar
• 39 Grimm W, Schwieder G, Wagner T. Fatal pulmonary embolism in venous thrombosis of the leg and pelvis during lysis therapy.  Dtsch Med Wochenschr. 1990;  115 1183-1187
  PubMedGoogle Scholar
• 40 Semba C P, Cake M D. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis.  Radiology. 1994;  191 487-494
  PubMedGoogle Scholar
• 41 Jamieson S W, Nomura K. Indications for and the results of pulmonary thromboendarterectomy for thromboembolic pulmonary hypertension.  Semin Vasc Surg. 2000;  13 236-244
  PubMedGoogle Scholar

Thomas B KinneyM.D. M.S.M.E. 

Professor of Clinical Radiology, UCSD Medical Center

200 West Arbor Drive, San Diego, CA 92103-8756